Zenflow Launches Pivotal Clinical Trial of Minimally Invasive Spring® Treatment for Enlarged Prostate Symptoms
04 oct. 2021 12h00 HE
|
Zenflow
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for enlarged prostate, or benign prostatic...
Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsight
22 avr. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, April 22, 2021 (GLOBE NEWSWIRE) -- Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsightThe Benign Prostatic Hyperplasia (BPH)...